Search

Search Constraints

You searched for: Author/Creator Pena, Loren

Search Results

2. Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4, 000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study. (October 2018)

3. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. Issue 12 (December 2021)

4. The genome empowerment scale: An assessment of parental empowerment in families with undiagnosed disease. Issue 6 (8th October 2019)